Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENZALUTAMIDE Cause Intentional dose omission? 176 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Intentional dose omission have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.4% of all adverse event reports for ENZALUTAMIDE.

176
Reports of Intentional dose omission with ENZALUTAMIDE
0.4%
of all ENZALUTAMIDE reports
18
Deaths
97
Hospitalizations

How Dangerous Is Intentional dose omission From ENZALUTAMIDE?

Of the 176 reports, 18 (10.2%) resulted in death, 97 (55.1%) required hospitalization, and 2 (1.1%) were considered life-threatening.

Is Intentional dose omission Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 176 reports have been filed with the FAERS database.

What Other Side Effects Does ENZALUTAMIDE Cause?

Fatigue (8,891) Death (6,680) Malignant neoplasm progression (4,696) Prostatic specific antigen increased (3,731) Asthenia (3,589) Drug ineffective (3,468) Hot flush (3,144) Decreased appetite (3,069) Nausea (2,898) Dizziness (2,776)

What Other Drugs Cause Intentional dose omission?

DUPILUMAB (2,269) CERTOLIZUMAB PEGOL (1,253) ADALIMUMAB (845) TOFACITINIB (845) INFLIXIMAB (815) ABALOPARATIDE (623) ETANERCEPT (615) AMBRISENTAN (595) SODIUM OXYBATE (580) CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (518)

Which ENZALUTAMIDE Alternatives Have Lower Intentional dose omission Risk?

ENZALUTAMIDE vs EPCORITAMAB ENZALUTAMIDE vs EPCORITAMAB-BYSP ENZALUTAMIDE vs EPERISONE ENZALUTAMIDE vs EPHEDRINE ENZALUTAMIDE vs EPINASTINE

Related Pages

ENZALUTAMIDE Full Profile All Intentional dose omission Reports All Drugs Causing Intentional dose omission ENZALUTAMIDE Demographics